The effect of Iberogast on heartburn in patients with functional dyspepsia - Iberogast and heartburn

Academisch Medisch Centrum0 个研究点目标入组 18 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•* Age above 18
•* A history of dyspepsia (according to the Rome IV criteria) with heartburn
•* Upper gastro-intestinal causes of the complaints excluded via gastroscopy with in addition an abdominal echography if deemed necessary by the physician

•* Surgery of the GI tract other than appendectomy or cholecystectomy
•* Use of any medication with a potential effect on gastrointestinal motility, secretion or sensitivity that cannot be stopped for the duration of the study (e.g. proton pump inhibitors, H2-blockers, antidepressants, prokinetics)
•* Proton pump inhibitors must be stopped at least 7 days before start of the study
•* Known Barrett*s oesophagus
•* History of GI cancer
•* Known allergy to one of the ingredients of Iberogast
•* Known diabetes
•* Severe and clinically unstable concomitant disease (e.g. liver, cardiovascular or lung disease, neurological or psychiatric disorders, cancer or AIDS and other endocrine disorders)
•* Pregnancy (women will be asked if they are pregnant)

发起方